Guard Therapeutics International AB (publ)
556755-3226ActiveSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Biotechnology Companyguardtherapeutics.com
Yleiskatsaus
- 5–9
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2008
- Perustettu
Kuvaus
Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...
Tunnisteet
B2BPharmaceuticalsPublicly Listed
ASAMEDIC AS